5-(2,4-dioxo-1H-quinazolin-3-yl)-N-[2-(4-methylphenyl)ethyl]pentanamide结构式
|
常用名 | 5-(2,4-dioxo-1H-quinazolin-3-yl)-N-[2-(4-methylphenyl)ethyl]pentanamide | 英文名 | 5-(2,4-dioxo-1H-quinazolin-3-yl)-N-[2-(4-methylphenyl)ethyl]pentanamide |
|---|---|---|---|---|
| CAS号 | 896356-19-7 | 分子量 | 379.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C22H25N3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-(2,4-dioxo-1H-quinazolin-3-yl)-N-[2-(4-methylphenyl)ethyl]pentanamide |
|---|
| 分子式 | C22H25N3O3 |
|---|---|
| 分子量 | 379.5 |
| InChIKey | AIQRIPGQMLDBJC-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)CCNC(=O)CCCCN2C(=O)C3=CC=CC=C3NC2=O |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|